Cargando…
Optical genome mapping identifies clinically relevant genomic rearrangements in prostate cancer biopsy sample
BACKGROUND: Prostate cancer (PCa) is characterized by complex genomic rearrangements such as the ETS oncogene family fusions, yet the clinical relevance is not well established. While paneled genetic tests of DNA repair genes are recommended in advanced PCa, conventional genomic or cytogenetic tools...
Autores principales: | Shim, Yeeun, Lee, Jongsoo, Seo, Jieun, Park, Cheol Keun, Shin, Saeam, Han, Hyunho, Lee, Seung-Tae, Choi, Jong Rak, Chung, Byung Ha, Choi, Young Deuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548106/ https://www.ncbi.nlm.nih.gov/pubmed/36209207 http://dx.doi.org/10.1186/s12935-022-02728-2 |
Ejemplares similares
-
t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia
por: Kim, Jieun, et al.
Publicado: (2016) -
Circulating Tumor DNA Analysis on Metastatic Prostate Cancer with Disease Progression
por: Bang, Sungun, et al.
Publicado: (2023) -
Androgen-Independent Prostate Cancer Is Sensitive to CDC42-PAK7 Kinase Inhibition
por: Han, Hyunho, et al.
Publicado: (2022) -
Development and validation of sensitive BCR::ABL1 fusion gene quantitation using next-generation sequencing
por: Lee, Hyeonah, et al.
Publicado: (2023) -
Characteristics of BRCA2 Mutated Prostate Cancer at Presentation
por: Han, Hyunho, et al.
Publicado: (2022)